About 80 percent of patients with moderate to severe psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab, according to three large, long-term clinical...
Read MoreLumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced that results from the clinical case series analyzing the UltraPulse® CO2 laser system will...
Read MoreAn upcoming merger agreement between Pfizer and Anacor, worth around $5.2 billion, could boost the marketing power of Anacor’s lead pipeline candidate, crisaborole, and pave the way for Pfizer to launch its...
Read MoreTSK has achieved to produce a needle 33% thinner than a 30G needle and 14% thinner than the TSK 33G needle. TSK Laboratory launches THE INViSIBLE NEEDLE™. It is the...
Read MoreALASTIN™ Skincare, Inc., a specialty skin care company dedicated to developing and marketing innovative, clinically-tested skin care products, announced the launch of the newest addition to their cosmeceutical skin care...
Read MoreAllergan plc announced that the New Drug Application (NDA) filing for oxymetazoline HCl cream 1.0%, an investigational topical prescription product for the treatment of persistent facial erythema (redness) associated with...
Read MoreFaced with increasing rates of skin cancer among Americans, the National Society for Cutaneous Medicine (NSCM) recently surveyed dermatologists nationwide to provide a unified perspective on how individuals and families...
Read MoreASEA, a global leader in cellular health, announced the launch of a new skincare line, RENU Advanced. With four products bundled as a skincare system, RENU Advanced is formulated for...
Read More